Compare BIO & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | FLR |
|---|---|---|
| Founded | 1952 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Military/Government/Technical |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.9B |
| IPO Year | N/A | N/A |
| Metric | BIO | FLR |
|---|---|---|
| Price | $301.39 | $41.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $358.50 | $49.57 |
| AVG Volume (30 Days) | 173.1K | ★ 2.8M |
| Earning Date | 02-12-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1235.20 |
| EPS | N/A | ★ 20.04 |
| Revenue | $2,557,500,000.00 | ★ $15,587,000,000.00 |
| Revenue This Year | $1.77 | N/A |
| Revenue Next Year | $2.30 | $5.34 |
| P/E Ratio | ★ N/A | $2.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $211.43 | $29.20 |
| 52 Week High | $373.69 | $57.50 |
| Indicator | BIO | FLR |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 40.72 |
| Support Level | $295.01 | $40.52 |
| Resistance Level | $307.07 | $45.23 |
| Average True Range (ATR) | 8.47 | 1.59 |
| MACD | -1.48 | -0.20 |
| Stochastic Oscillator | 20.12 | 10.29 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.